Skip to main content

Table 6 Reasons for first, subsequent use and no use of SCRAs with most important reason for each highlighted and italicised

From: The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients

First SCRA use (n = 82) Reasons for SCRA use
n, %
Most important reason
n, %
Curiosity to compare effects to cannabis 63 77% 18 22%
Offered by others/available 51 62% 15 18%
Heard reports from other sources 50 61% 7 9%
Offered an alternative to cannabis 42 51% 13 16%
Legal status 42 51% 10 12%
Easier to obtain than cannabis 31 38% 4 5%
Subject to drug testing 20 24% 7 9%
To reduce or cease cannabis use 15 18% 6 7%
Produced desirable recreational effects 14 17% - -
Less expensive than cannabis 10 12% 1 1%
Stronger than cannabis 10 12% 1 1%
Produced positive therapeutic/medicinal effects 7 9% - -
Milder than cannabis 4 5% - -
Subsequent SCRA use (n = 72)
Offered an alternative to cannabis 37 51% 7 10%
Easier to obtain than cannabis 34 47% 7 10%
Stronger than cannabis 33 44% 13 18%
Legal status 31 43% 7 10%
Offered by others/available 31 43% 9 13%
Produced desirable recreational effects 22 31% 6 8%
Subject to drug testing 20 28% 9 13%
Curiosity to compare effects to cannabis 19 26% 9 13%
Produced positive therapeutic/medicinal effects 10 14% - -
Less expensive than cannabis 9 13% 3 4%
To reduce or cease cannabis use 8 11% 2 3%
Heard reports from other sources 8 11% - -
Milder than cannabis 5 7% - -
No SCRA use (n = 72)
Heard bad/negative reports 62 86% 37 51%
Not a natural product 50 69% 17 24%
No curiosity to try SCRAs 40 56% 5 7%
Undesired recreational effects 38 53% 7 10%
Distrust of SCRA manufacturers 20 28% 2 3%
Never offered or available 14 19% 4 6%
Negative/harmful effect profile 14 19% - -
Distrust of SCRA retailers 11 15% - -
Illegal status 9 13% - -
More difficult to obtain 8 11% - -
Stronger than cannabis 5 7% - -
Subject to drug testing 3 4% - -
More expensive 2 3% - -
Milder than cannabis 2 3% - -